Aevice Health: How the world’s smallest wearable stethoscope transforms asthma treatment
Asthma is one of the most widespread respiratory diseases, affecting more than 260 million people worldwide. While genetic factors play a role, asthma is also strongly influenced by stress levels, physical activity, and air quality. It is linked to an estimated 455,000 fatal cases annually, with most premature deaths occurring in low- and middle-income countries where the condition often remains underdiagnosed and undertreated.
Nexmedis, an AI-powered health information system provider, secures funding co-led by East Ventures and Forge Ventures
Nexmedis, an Indonesia-based AI-powered Health Information System (HIS) provider, has secured an undisclosed amount of funding co-led by East Ventures and Forge Ventures. This funding will propel Nexmedis’ mission to revolutionize healthcare operations, enhance clinical services, and improve patient outcomes across Indonesia.
Consumption tech offers hope amid challenges in startup funding
In the challenging landscape of startup funding, characterized by economic uncertainties and fluctuating investment climates, consumption tech offers a beacon of potential recovery, said panelists at DealStreetAsia’s Indonesia PE-VC Summit 2025 last week.
What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection
The Indonesian healthcare landscape has improved significantly in the past decade. It has strengthened access to funding through the successful rollout of the BPJS Kesehatan, or universal healthcare, and the successful reforms implemented through the Omnibus Law that we will see in the coming years.
PathGen raises funding from East Ventures and Royal Group Indonesia, making early disease detection and precision medicine more accessible
PathGen or PathGen Diagnostik Teknologi, an Indonesia-based healthcare biotechnology startup specializing in molecular testing solutions, has raised funding from East Ventures and Royal Group Indonesia
Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale
Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round of investment is also participated by Elev8, Seed Capitals, and other existing shareholders.
East Ventures announced its first Healthcare fund of US$30 million
East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, today announced the firm’s first healthcare-focused fund with the amount of US$30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.
Mesh Bio, a health deep tech startup, secured investment from East Ventures
Mesh Bio, a Singapore-based health deep tech startup in transforming chronic disease management through predictive analytics, announced that it had raised an undisclosed amount of funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. The funding will be allocated to further develop the digital twin technologies in chronic disease management and to expand its services across Southeast Asia, mainly Indonesia, Malaysia, and the Philippines.